Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreichs Ataxia on Monday, May 18, 2026
May 17, 2026 16:00 ET | Source: Design Therapeutics, Inc. CARLSBAD, Calif.,…
ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026
– Complete response (CR) observed in 70% (50/72) of evaluable patients with…
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and,…
YASH Technologies Recognized as a Major Contender in Everest Group’s Digital Workplace Services PEAK Matrix Assessment 2026 – Mid-market Enterprises
CHICAGO, May 14, 2026 /PRNewswire/ -- YASH Technologies, a global technology services…
MEXC Confirms Strong Asset Backing in Hacken-Audited May 2026 Proof of Reserves Report
VICTORIA, Seychelles, May 14, 2026 /PRNewswire/ -- MEXC, a pioneer in 0-fee…
UPDATE Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
TARRYTOWN, N.Y. and WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals,…
Range Impact Reports 1Q 2026 Financial Results
CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC:…
Remote People Named Best Employer of Record (EOR) for SMBs by SelectSoftwareReviews in 2026 Buyer Guide
Remote People takes the #1 position in SelectSoftwareReviews' Q2 2026 ranking of…
Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
Vaso Corporation Announces Financial Results for First Quarter of 2026
May 15, 2026 09:00 ET | Source: Vaso Corporation PLAINVIEW, N.Y., May…
